MIRIKIZUMAB REDUCES ABDOMINAL PAIN IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE

Edward V. Loftus ¹ Paul Pollack ² Theresa Hunter Mingyang Shan Lai Shan Chan Deanilee Deckard Raymond Cross ³
¹ Mayo Clinic College of Medicine, Rochester, United States
² Eli Lilly and Company, Indianapolis, United States
³ University of Maryland, Baltimore, United States

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)

Do you need help setting up your myUEG account?
Contact us at [email protected]

Social Sharing